SMI Equal Weight
401,07
PKT
+0,02
PKT
±0,00
%
Werbung
Analysen zu SMI Equal Weight-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 06.11.12 | Swisscom outperform | Exane-BNP Paribas SA | |
| 06.11.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 06.11.12 | Holcim hold | Société Générale Group S.A. (SG) | |
| 06.11.12 | Partners Group buy | Sarasin Research | |
| 05.11.12 | Swiss Re sell | Goldman Sachs Group Inc. | |
| 05.11.12 | Novartis neutral | Citigroup Corp. | |
| 05.11.12 | Holcim buy | Société Générale Group S.A. (SG) | |
| 05.11.12 | Partners Group hold | Vontobel Research | |
| 05.11.12 | Partners Group neutral | Sarasin Research | |
| 05.11.12 | UBS buy | Citigroup Corp. | |
| 06.11.12 | Novartis outperform | Exane-BNP Paribas SA | |
| 02.11.12 | Swiss Re buy | Société Générale Group S.A. (SG) | |
| 02.11.12 | UBS hold | Société Générale Group S.A. (SG) | |
| 02.11.12 | UBS buy | Société Générale Group S.A. (SG) | |
| 02.11.12 | Geberit hold | Vontobel Research | |
| 01.11.12 | UBS buy | Nomura | |
| 01.11.12 | Lonza hold | Vontobel Research | |
| 01.11.12 | Sika hold | Vontobel Research | |
| 01.11.12 | Swisscom hold | Vontobel Research | |
| 01.11.12 | UBS halten | Independent Research GmbH | |
| 01.11.12 | UBS buy | Sarasin Research | |
| 01.11.12 | Swisscom neutral | Sarasin Research | |
| 31.10.12 | UBS outperform | Exane-BNP Paribas SA | |
| 31.10.12 | UBS hold | Deutsche Bank AG | |
| 31.10.12 | UBS overweight | J.P. Morgan Cazenove | |
| 31.10.12 | Sika underperform | Cheuvreux SA | |
| 31.10.12 | Zurich Insurance neutral | J.P. Morgan Cazenove | |
| 31.10.12 | Geberit neutral | UBS AG | |
| 31.10.12 | UBS overweight | Morgan Stanley | |
| 31.10.12 | UBS outperform | RBC Capital Markets | |
| 31.10.12 | Sika neutral | Sarasin Research | |
| 31.10.12 | Sika hold | Vontobel Research | |
| 31.10.12 | Lonza hold | Vontobel Research | |
| 31.10.12 | ABB (Asea Brown Boveri) outperform | Sanford C. Bernstein and Co., Inc. | |
| 30.10.12 | UBS hold | Commerzbank Corp. & Markets | |
| 30.10.12 | Novartis buy | Deutsche Bank AG | |
| 30.10.12 | Zurich Insurance hold | Vontobel Research | |
| 30.10.12 | UBS underperform | Cheuvreux SA | |
| 30.10.12 | Geberit outperform | Cheuvreux SA | |
| 30.10.12 | Nestlé hold | Vontobel Research |